Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study-Reference-Cited by-同舟云学术

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

Published:2017-03 Issue:3 Volume:28 Page:634-641
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

McArthur G.A.,Maio M.,Arance A.,Nathan P.,Blank C.,Avril M.-F.,Garbe C.,Hauschild A.,Schadendorf D.,Hamid O.,Fluck M.,Thebeau M.,Schachter J.,Kefford R.,Chamberlain M.,Makrutzki M.,Robson S.,Gonzalez R.,Margolin K.

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/3/634/11203289/mdw641.pdf

Reference16 articles.

1. Prognostic factors for survival in melanoma patients with brain metastases;Davies;Cancer,2011

2. Determinants of outcome in melanoma patients with cerebral metastases;Fife;J Clin Oncol,2004

3. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma;Eigentler;Cancer,2011

4. Clinical management of multiple melanoma brain metastases: a systematic review;Goyal;JAMA Oncol,2015

5. The treatment of brain metastases from malignant melanoma;Douglas;Semin Oncol,2002

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastasis;Hematology/Oncology Clinics of North America;2024-10

2. Advances in Personalized Oncology;Cancers;2024-08-16

3. Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management;Cancers;2024-07-19

4. Patterns of brain metastases response to immunotherapy with pembrolizumab;Journal of Neuro-Oncology;2024-07-04

5. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part I;Critical Reviews in Oncology/Hematology;2024-07